Being Patient: The Latest Developments on Alzheimer's Disease

Latest News

FDA Moves Forward on Aducanumab

By Phil Gutis | August 7th, 2020

In yet another encouraging step toward the development of what could be the first drug approved for Alzheimer’s disease, the Federal Drug Administration today…

Can Memory Loss Be Reversed? An Experimental Drug Reports Success, Pursues Clinical Trials

By Alexandra Marvar | August 7th, 2020

In a new mouse study, Salk researchers found a drug, CMS121, that appears to treat neurodegeneration in mice. Researchers at the Salk Institute for…

Alzheimer's dementia lifestyle prevention riskfactors

12 Things You Can Do To Help Prevent or Delay Dementia

By Nicholas Chan | August 6th, 2020

While dementia is not necessarily preventable, scientists now understand even more clearly the extent to which some lifestyle changes can significantly lower one’s odds…

9/11 First Responders Increased Dementia Risk

9/11 First Responders Showing Signs of Cognitive Impairment and Dementia

By Alexandra Marvar | August 5th, 2020

Nearly 20 years after the 9/11 terrorist attacks, clinicians are seeing more 9/11 first responders display signs of cognitive disorders and possible dementia. Two…

Being Patient: Brain Talks

Dr. Eugenia Trushina: Preventing Alzheimer’s Through Mitochondrial Restoration

Being Patient spoke with Dr. Eugenia Trushina, a researcher at the Mayo Clinic, about her work on the restoration of mitochondria in the brain and its potential to prevent and even reverse neurodegeneration from Alzheimer’s.

Brain Health and the Pandemic

By Nicholas Chan | June 30th, 2020

After Recovering From COVID-19, Patients May Require Neurological Testing

Researchers are urging COVID-19 patients to see a neurologist six to eight months after their hospital discharge if they are experiencing cognitive issues, like…

By Tanner Jensen | July 17th, 2020

Looking to the Future: What Are the Long-Term Effects of COVID-19?

As research into COVID-19 continues, mounting evidence suggests that the disease may cause significant brain damage in some recovered patients. Some researchers have focused…

coronavirus caused a surge in alzheimer's deaths

By Alexandra Marvar | July 14th, 2020

Five Reason The Coronavirus Pandemic Has Caused a Surge in Alzheimer’s Deaths

The National Center for Health Statistics attributes 266,000 deaths per year to Alzheimer’s and other forms of dementia. Upwards of 120,000 of those per…

By Nicholas Chan | June 24th, 2020

Viruses and Bacteria Change Our Brains. What Can That Teach Us About Alzheimer’s?

Some brain health researchers are taking a closer look at how viruses and bacteria affect the brain, and rethinking the villainous role of Alzheimer’s…

The Quest to Cure Alzheimer's

By Alexandra Marvar | July 2nd, 2020

A Common Asthma Drug Shows Promise as a Treatment for Alzheimer’s

A new study reveals that the asthma drug salbutamol may offer potential as a treatment for Alzheimer’s disease. Alzheimer’s Disease takes hundreds of thousands…

By Phil Gutis | July 8th, 2020

Biogen Seeks FDA Approval for Alzheimer’s Drug Aducanumab

In another step toward what could be the first treatment for early stage Alzheimer’s, Biogen and Eisai today said they have completed an application…

By Alexandra Marvar | July 9th, 2020

Scientists Have Discovered a Way to Speed Up Alzheimer’s Drug Testing

Alzheimer’s clinical trials may take decades, but a new discovery could cut clinical trial time down to a matter of weeks. For nearly a century,…

By Alexandra Marvar | June 11th, 2020

Alzheimer’s Researchers Bring in the Baboons

The newest possible model to test therapeutics and interventions for neurodegenerative diseases could be a 20-year-old baboon. A team at Texas Biomedical Research Institute’s…

By Phil Gutis | July 15th, 2020

As Gun Ownership Soars, Researchers Find One Third of People with Dementia Have Access to Firearms at Home

New research raises concerns about access to guns for people with dementia, and caregivers search for expert guidance on how to address gun safety…

covid-19 can cause neuropsychiatric conditions

By Alexandra Marvar | April 22nd, 2020

Will COVID-19 Cause Lifelong Neuropsychiatric Conditions?

Because of their lasting effects on the brain, strains of the coronavirus — possibly including COVID-19 — could cause the onset of some of…

prevagen false advertising lawsuit settlement

By Alexandra Marvar | June 29th, 2020

Prevagen False Advertising Settlement Could Help Regulate the Wild West of Brain Health Supplements

A settlement in a false advertising lawsuit involving brain health supplement Prevagen could be one of the largest consumer class settlements in the U.S.,…

By Alexandra Marvar | May 25th, 2020

‘Always Get A Second Opinion’: Fraudulent Doc Indicted for Fake Alzheimer’s Diagnoses

The science behind Alzheimer’s is constantly developing, but its cause remains elusive and the disease is frequently misdiagnosed. A 2017 study at a hospital…

Genetics and the Brain

By Alexandra Marvar | July 13th, 2020

Meet BACE2, a Gene That Can Naturally Suppress Alzheimer’s

Can a gene that naturally suppresses Alzheimer’s in brain cells pave the way to curing it? In 2012, excitement rippled through the scientific community…

By Nicholas Chan | April 17th, 2020

New Genetic Variant Discovered to Protect Against Risk of Alzheimer’s Gene ApoE4

The Alzheimer’s gene, known as ApoE4, is one of the the largest genetic risk factors for later onset Alzheimer’s disease. Carrying one copy of the…

By Lecia Bushak | March 2nd, 2020

Researchers Identify New Alzheimer’s Biomarker in PSEN1 Gene

Researchers have identified a gene called Presenilin1, or PSEN1, as a potential new biomarker for Alzheimer’s disease. In mice and human samples, the researchers…

By Phil Gutis | February 7th, 2020

Researchers Pinpoint Genetic Mutations That May Protect Against Alzheimer’s

Scientists in London have identified a type of genetic mutation that appears to protect against late-onset Alzheimer’s disease. For their paper, published in the…

Patient and Caregiver Perspectives

By Trish Laub | July 3rd, 2020

The latest news on Alzheimer’s disease and brain health research

Latest News

FDA Moves Forward on Aducanumab

Can Memory Loss Be Reversed? An Experimental Drug Reports Success, Pursues Clinical Trials

12 Things You Can Do To Help Prevent or Delay Dementia

9/11 First Responders Showing Signs of Cognitive Impairment and Dementia

More Articles

Being Patient: Brain Talks

Dr. Eugenia Trushina: Preventing Alzheimer’s Through Mitochondrial Restoration

More Videos

Brain Health and the Pandemic

After Recovering From COVID-19, Patients May Require Neurological Testing

Looking to the Future: What Are the Long-Term Effects of COVID-19?

Five Reason The Coronavirus Pandemic Has Caused a Surge in Alzheimer’s Deaths

Viruses and Bacteria Change Our Brains. What Can That Teach Us About Alzheimer’s?

More Articles

The Quest to Cure Alzheimer's

A Common Asthma Drug Shows Promise as a Treatment for Alzheimer’s

Biogen Seeks FDA Approval for Alzheimer’s Drug Aducanumab

Scientists Have Discovered a Way to Speed Up Alzheimer’s Drug Testing

Alzheimer’s Researchers Bring in the Baboons

Brain Health in the Headlines

As Gun Ownership Soars, Researchers Find One Third of People with Dementia Have Access to Firearms at Home

Will COVID-19 Cause Lifelong Neuropsychiatric Conditions?

Prevagen False Advertising Settlement Could Help Regulate the Wild West of Brain Health Supplements

‘Always Get A Second Opinion’: Fraudulent Doc Indicted for Fake Alzheimer’s Diagnoses

More Articles

Genetics and the Brain

Meet BACE2, a Gene That Can Naturally Suppress Alzheimer’s

New Genetic Variant Discovered to Protect Against Risk of Alzheimer’s Gene ApoE4

Researchers Identify New Alzheimer’s Biomarker in PSEN1 Gene

Researchers Pinpoint Genetic Mutations That May Protect Against Alzheimer’s

More Articles

Patient and Caregiver Perspectives

Words Matter: The Pandemic Shines the Light on a Culture of Ageism

Phil’s Journal: Being Part of Scientific History, or, a New Phase of the Biogen Trial

When a Loved One with Dementia Dies from COVID-19: A Granddaughter Shares Her Story

‘Misdiagnosed by Six Different Neurologists:’ Don Kent on Recognizing Lewy Body Dementia and His Journey to a Diagnosis

See All Voices